MedPath

Peri-operative Foot CT Perfusion in CLI Patients

Active, not recruiting
Conditions
Critical Limb Ischemia
Registration Number
NCT05575778
Lead Sponsor
Fudan University
Brief Summary

To investigate the clinical value of quantitative analysis of peri-operative foot supply through CT perfusion in patients with critical limb ischemia

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • 18 to 80 years old;
  • CLI patients with Fontaine grade III-IV or Rutherford grade 4-6 and underwent a successful revascularization;
  • Patients completed both pre- and post-operative CTP workups;
  • Patients signed the informed consent form and be able to complete the clinical follow-up for 12 months.
Read More
Exclusion Criteria
  • Patients has participated in other clinical studies;
  • Patients with Heart failure (NYHA III/IV)/right to left shunt heart disease/severe aortic and mitral insufficiency/acute coronary syndrome/malignant arrhythmia/severe pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)/moderate to severe renal insufficiency (creatinine clearance rate<60 ml/min)
  • Any allergic constitution;
  • Pregnancy and childbirth;
  • Life expectancy<12 months.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pre-operative computed tomographic perfusion parameters18months

Pre-operative computed tomographic perfusion parameters, including peak intensity, time to peak, and etc, which would be obtained three days before revascularization.

Post-operative computed tomographic perfusion parameters18months

Post-operative computed tomographic perfusion parameters, including peak intensity, time to peak, and etc, which would be obtained three days ater revascularization.

Alteration of computed tomographic perfusion parameters18months

Alteration between post- (three days ater revascularization) and pre-operative (three days before revascularization) computed tomographic perfusion parameters

Secondary Outcome Measures
NameTimeMethod
Major adverse limb events12months

Major adverse limb events included major amputation or acute limb ishchemia for vasular causes.

Major adverse cardiovascular events12months

Major adverse cardiovascular events included myocardial infarction, ischemic stroke, or death from cadiovascular causes.

Trial Locations

Locations (1)

Hua Dong Hospital Affiliated to Fu Dan University

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath